Site icon fundsforNGOs

Grants for Development of Safe, Real-Time, Non-Invasive Methods (US)

Deadline: 5-Jan-23

The National Institutes of Health (NIH) invites grant applications that seek to advance or clinically validate emerging novel approaches for the development of safe, real-time, non-invasive (or minimally invasive) methods to assess the development and function of the human placenta across pregnancy.

This FOA is for the advancement of novel methods for assessing the placenta’s real time in vivo status with the ultimate goal of human use across pregnancy. Special consideration will be given to applications that develop methods that are applicable throughout pregnancy, preferably starting in early gestation during the period of trophoblast invasion and remodeling of the uterine spiral arteries, and which facilitate assignment of relative risk for pregancy complications.

The placenta is a dynamic organ which changes over the course of pregnancy. To be helpful, assessments need to yield results within a time frame that reflects the current structural/functional status. However, real-time is not meant to imply instantaneous results.

Program Priorities

As the goal of this FOA is to support research-driven technology development to meet the objectives of the HPP, program priority will be given to applications that are exceptional in the following aspects: 

Duration

The scope of the proposed project should determine the project period. The maximum project period is 5 years.

Eligibility Criteria

For more information, visit Grants.gov.

For more information, visit https://www.grants.gov/web/grants/view-opportunity.html?oppId=343745

Exit mobile version